Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures
Clinical trial NCT00975715 · COMPLETED
Trial details
- NCT number
- NCT00975715
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2012-10-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.